Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors
NCT01351727 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97
Last updated 2017-11-06
Summary
The purpose of this proposed research is to identify individuals in southeastern Arizona aged 65 years and older who have new onset seizures (or newly diagnosed epilepsy) and monitor them for at least two years. In doing so the investigators will be able to describe the public health burden of this condition and to identify factors that predict clinical outcomes and health care needs in this population, using quantitative, administrative, and qualitative data. The aims of this proposed research are 1) to determine the two-year incidence of newly diagnosed epilepsy in the target population, 2) describe health care resource utilization of the target population using Medicare data, 3) validate the use of Medicare beneficiary data to estimate incidence of epilepsy, and 4) describe the burden of this condition in different ethnic groups.
Conditions
- Epileptic Seizures
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED -
University of Arizona
lead OTHER
Principal Investigators
-
David Labiner, MD · University of Arizona
-
Jenny Chong, PhD · University of Arizona
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2014-09-30
- Completion
- 2014-09-30
Countries
- United States
Study Locations
More Related Trials
-
The Human Epilepsy Project
NCT02126774 ·Status: COMPLETED
-
Late-Onset Seizures: Trial of Vascular Risk Investigation and Treatment
NCT07116330 ·Status: RECRUITING
-
Lamotrigine Extended-Release In Elderly Patients With Epilepsy
NCT00516139 ·Status: COMPLETED ·Phase: PHASE3
-
Precision Medicine in the Treatment of Epilepsy
NCT05450822 ·Status: RECRUITING
-
Factors Associated With in Suboptimal Prescribing for Older Patients With Epilepsy
NCT00144001 ·Status: COMPLETED
-
Medication Adherence in Individuals With Epilepsy
NCT01566500 ·Status: COMPLETED
-
Human Epilepsy Project 3
NCT05374928 ·Status: ACTIVE_NOT_RECRUITING
-
An Open Label, Randomised, Repeat Dose Study to Assess the Pharmacokinetic Performance of Five Ezogabine/Retigabine Modified Release (MR) Formulations at Steady State Compared to the Immediate Release (IR) Formulation.
NCT01332513 ·Status: COMPLETED ·Phase: PHASE1
-
Intermittent Fasting in Refractory Epilepsy
NCT02311023 ·Status: TERMINATED ·Phase: PHASE2
-
Prevalence and Pattern of Headache in Pediatric Epilepsy
NCT06868251 ·Status: NOT_YET_RECRUITING
-
The Role of Gut Microbiota in Children With Epilepsy Following Ketogenic Diet
NCT05898438 ·Status: UNKNOWN
-
A Study of the Prevalence of Headache in Epileptic Patients
NCT00277368 ·Status: COMPLETED
-
Human Epilepsy Project 2: Resistant Focal Seizures Study
NCT03531008 ·Status: COMPLETED
-
Study of Specimens Obtained During Epilepsy Surgery
NCT00025714 ·Status: COMPLETED
-
Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda
NCT05698537 ·Status: COMPLETED
-
Ciprofloxacin in Drug-resistant Epilepsy
NCT04763070 ·Status: COMPLETED ·Phase: NA
-
Rolandic Epilepsy Genomewide Association International Study
NCT03547050 ·Status: COMPLETED
-
Is Protein S100B a Predictor of First-to-chronic Seizure Conversion in Adults?
NCT02424123 ·Status: TERMINATED
-
Tumor Related Epilepsy
NCT02639325 ·Status: RECRUITING
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
NCT05605301 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation Of A Mobile Messaging Service In Improving Adherence Of Anti-Seizure Medications
NCT05321641 ·Status: UNKNOWN ·Phase: NA
-
Cannabis Extract in Refractory Epilepsy Study
NCT03808935 ·Status: TERMINATED ·Phase: PHASE3
-
Epilepsy-Associated Stigma
NCT01374204 ·Status: COMPLETED
-
Acid Suppressing Drug Seizure Epidemiology Study
NCT01744301 ·Status: COMPLETED